naftazone (cas 15687-37-3) in advanced Parkinson's disease: An acute L-DOPA challenge randomized controlled trial
-
Add time:09/01/2019 Source:sciencedirect.com
IntroductionThere is an unmet need to better control motor complications in Parkinson's disease (PD). naftazone (cas 15687-37-3), which exhibits glutamate release inhibition properties, has shown antiparkinsonian and antidyskinetic activity in preclinical models of PD and in a clinical proof of concept study.
We also recommend Trading Suppliers and Manufacturers of naftazone (cas 15687-37-3). Pls Click Website Link as below: cas 15687-37-3 suppliers
Prev:Preparation and characterization of NiFe2O4/activated carbon composite as potential magnetic adsorbent for removal of Ibuprofen (cas 15687-27-1) and ketoprofen pharmaceuticals from aqueous solutions
Next:Analytical MethodsSimultaneous determination of clanobutin, dichlorvos, and naftazone (cas 15687-37-3) in pork, beef, chicken, milk, and egg using liquid chromatography-tandem mass spectrometry) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Dosage des médicaments par spectrophotométrie in situ des chromatogrammes en vue de leur étude pharmacocinétique : I. Sulpiride et autres benzamides, vincamine, naftazone (cas 15687-37-3)09/07/2019
- Acute and chronic haemodynamic effects of naftazone (cas 15687-37-3) in portal hypertensive rats109/06/2019
- Lipid peroxidation and lysosomal integrity in different inflammatory models in rats: The effects of indomethacin and naftazone (cas 15687-37-3)09/05/2019
- Fungal metabolite of naftazone (cas 15687-37-3) inhibits nitrite production by activated murine macrophages09/04/2019
- naftazone (cas 15687-37-3) reduces glutamate cerebro spinal fluid levels in rats and glutamate release from mouse cerebellum synaptosomes09/03/2019
- Analytical MethodsSimultaneous determination of clanobutin, dichlorvos, and naftazone (cas 15687-37-3) in pork, beef, chicken, milk, and egg using liquid chromatography-tandem mass spectrometry09/02/2019